iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Reaches New 12-Month High – Here’s What Happened

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) shares reached a new 52-week high during trading on Tuesday . The company traded as high as $105.15 and last traded at $104.90, with a volume of 14303 shares traded. The stock had previously closed at $103.08.

iShares U.S. Pharmaceuticals ETF Price Performance

The firm has a market cap of $1.74 billion, a price-to-earnings ratio of 17.75 and a beta of 0.48. The company has a fifty day moving average price of $99.95 and a two-hundred day moving average price of $92.58.

Institutional Investors Weigh In On iShares U.S. Pharmaceuticals ETF

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Foundations Investment Advisors LLC acquired a new position in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter worth approximately $54,513,000. BNP Paribas Financial Markets bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 2nd quarter worth approximately $13,108,000. Anfield Capital Management LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at approximately $10,007,000. JPMorgan Chase & Co. lifted its stake in iShares U.S. Pharmaceuticals ETF by 89.4% during the fourth quarter. JPMorgan Chase & Co. now owns 212,805 shares of the company’s stock valued at $18,052,000 after purchasing an additional 100,426 shares during the last quarter. Finally, Cetera Investment Advisers lifted its stake in iShares U.S. Pharmaceuticals ETF by 675.4% during the first quarter. Cetera Investment Advisers now owns 109,471 shares of the company’s stock valued at $9,489,000 after purchasing an additional 95,353 shares during the last quarter.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.